1 Supplementary Materials Therapeutic targeting of the oncostatin M receptor-β prevents inflammatory heart failure Jochen Pöling 1,2* ; Praveen Gajawada 1* , Manfred Richter 3 , Holger Lörchner 1 , Silvia Schimanski 1 , Victoria Polyakova 1,3 , Sawa Kostin 1 , Jaeyoung Shin 1 , Thomas Boettger 1 , Thomas Walther 3 , Wolfgang Rees 2 ; Astrid Wietelmann 1 , Henning Warnecke 2,4 , Thomas Kubin 1# and Thomas Braun 1# 1 Department of Cardiac Development and Remodelling, Max Planck Institute for Heart and Lung Research, Ludwigstrasse 43, Bad Nauheim, 61321, Germany 2 Department of Cardiac Surgery, Schüchtermann-Clinic, Ulmenallee 5, Bad Rothenfelde, 49214, Germany 3 Department of Cardiac Surgery, Kerckhoff Hospital, Benekestrasse 2-8, Bad Nauheim, 61231, Gerrmany 4 University of Witten/Herdecke, Alfred-Herrhausen-Straße 50, 58448, Germany
4
Embed
Therapeutic targeting of the oncostatin M receptor-β …10.1007...Therapeutic targeting of the oncostatin M receptor- β prevents inflammatory heart failure Jochen Pöling1,2*; Praveen
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Supplementary Materials
Therapeutic targeting of the oncostatin M receptor-β prevents inflammatory heart failure